लोड हो रहा है...
Workup and Management of Immune‐Mediated Colitis in Patients Treated with Immune Checkpoint Inhibitors
As the use of immune checkpoint inhibitors for several different malignancies becomes more mainstream, their side‐effect profile raises new challenges. In 2011, the Food and Drug Administration approved the first checkpoint inhibitor for the treatment of advanced melanoma, and since then, checkpoint...
में बचाया:
| में प्रकाशित: | Oncologist |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley & Sons, Inc.
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7066712/ https://ncbi.nlm.nih.gov/pubmed/32162824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0304 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|